The estimated Net Worth of Troy Wichterman is at least $3.82 Milhão dollars as of 29 May 2024. Mr Wichterman owns over 574 units of Biolife Solutions Inc stock worth over $2,921,221 and over the last 3 years he sold BLFS stock worth over $603,273. In addition, he makes $290,720 as Chief Financial Officer at Biolife Solutions Inc.
Mr has made over 35 trades of the Biolife Solutions Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 574 units of BLFS stock worth $12,502 on 29 May 2024.
The largest trade he's ever made was selling 10,310 units of Biolife Solutions Inc stock on 20 March 2023 worth over $213,211. On average, Mr trades about 608 units every 18 days since 2021. As of 29 May 2024 he still owns at least 125,969 units of Biolife Solutions Inc stock.
You can see the complete history of Mr Wichterman stock trades at the bottom of the page.
Troy Wichterman is the Chief Financial Officer at Biolife Solutions Inc.
As the Chief Financial Officer of Biolife Solutions Inc, the total compensation of Mr Wichterman at Biolife Solutions Inc is $290,720. There are 7 executives at Biolife Solutions Inc getting paid more, with Michael Rice having the highest compensation of $2,241,770.
Mr Wichterman is 36, he's been the Chief Financial Officer of Biolife Solutions Inc since . There are 17 older and no younger executives at Biolife Solutions Inc. The oldest executive at Biolife Solutions Inc is Thomas Girschweiler, 61, who is the Director.
Troy's mailing address filed with the SEC is 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.
Over the last 22 years, insiders at Biolife Solutions Inc have traded over $156,215,880 worth of Biolife Solutions Inc stock and bought 12,236,637 units worth $91,960,074 . The most active insiders traders include Partners Master Fund, L.P.C..., Thomas Girschweiler, eWalter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,018,157. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth $63,090.
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Biolife Solutions Inc executives and other stock owners filed with the SEC include: